Sinphar Pharmaceutical Co.,Ltd. (1734.TW)
Taiwan · TWD · Healthcare · Biotechnology
NT$30.70 (+0.00%) as of
Key statistics
- Market cap
- 6.56B
- P/E (TTM)
- 18.72
- EPS (TTM)
- 1.64
- Dividend yield
- 3.07%
- 52-week range
- 26.52 – 32.80
- Beta
- 0.11
- Revenue (TTM)
- 3.45B
- Profit margin
- 10.19%
- Volume
- 102.70k
About Sinphar Pharmaceutical Co.,Ltd.
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Yilan City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.